XOMA Reports Fourth Quarter and Full Year 2017 Financial Results and Provides Business Update
Mar 07, 2018 21:06 pm UTC| Business
Transformed business model to a royalty aggregator with extensive asset portfolio and capital;Added nine new partner-funded programs in 2017 with potential for milestone and royalty payments;Current cash balance sufficient...
iPass to Present at the 30th Annual ROTH Conference
Mar 07, 2018 21:06 pm UTC| Business
REDWOOD SHORES, Calif., March 07, 2018 -- iPass Inc. (NASDAQ:IPAS), a leading provider of global mobile connectivity, announced Chief Executive Officer Gary Griffiths is scheduled to participate in a fireside chat at...
ZAGG Announces Executive Leadership Transition
Mar 07, 2018 21:06 pm UTC| Business
SALT LAKE CITY, March 07, 2018 -- ZAGG Inc (Nasdaq:ZAGG), a leading global mobile lifestyle company, announced today that Randy Hales will retire as ZAGG’s President and CEO after serving in the role for the past six...
Evoke Pharma Reports Fourth Quarter and Full Year 2017 Financial Results and Recent Highlights
Mar 07, 2018 21:06 pm UTC| Business
Successfully completed pivotal pharmacokinetic trial and finalized the proposed to-be-marketed Gimoti™ doseAnnounced discovery of sex-based pharmacokinetic differences for Gimoti™Met with FDA regarding NDA women-only...
Service Corporation International Receives ‘Great Place to Work®’ Certification
Mar 07, 2018 21:06 pm UTC| Business
HOUSTON, March 07, 2018 -- Service Corporation International (NYSE:SCI), North America’s largest provider of funeral and cemetery services, announced today it has been certified as a great workplace by the independent...
Avid Bioservices Declares Quarterly Dividend on Its Series E Convertible Preferred Stock
Mar 07, 2018 21:06 pm UTC| Business
TUSTIN, Calif., March 07, 2018 -- Avid Bioservices, Inc. (NASDAQ:CDMO) (NASDAQ:CDMOP), a dedicated contract development and manufacturing organization (CDMO) working to improve patient lives by providing high quality...
Conatus Pharmaceuticals Reports 2017 Financial Results and Program Updates
Mar 07, 2018 21:06 pm UTC| Business
SAN DIEGO, March 07, 2018 -- Conatus Pharmaceuticals Inc. (Nasdaq:CNAT), a biotechnology company focused on the development and commercialization of novel medicines to treat liver disease, today announced financial...
FxWirePro- Major Economic events for the day